logo
‘The Skin Art Clinic' – A Lucknow-Based Cosmetic Dermatology Clinic Catering to Mumbai's Elite

‘The Skin Art Clinic' – A Lucknow-Based Cosmetic Dermatology Clinic Catering to Mumbai's Elite

In a recent press conference held in Mumbai, Dr. Nidhi Singh Tandon, the founder of The Skin Art Clinic, discussed how her Lucknow-based clinic is becoming the preferred destination for skincare, not only in Uttar Pradesh but across India. With the cosmetic dermatology industry traditionally dominated by metropolitan cities like Delhi, Mumbai, and Bangalore, The Skin Art Clinic has managed to carve out a significant presence by offering personalized care, ethical practices, and cutting-edge technology.
Dr. Nidhi Singh Tandon
The press conference, which was attended by several key media personnel and industry experts, highlighted a unique approach to skincare. A recent survey conducted across major cities like Delhi, Mumbai, and Bangalore by 3EA revealed that The Skin Art Clinic has become the top choice for many patients seeking results-driven treatments. Notably, the clinic has gained significant attention from individuals in Mumbai and Delhi, with many now traveling to Lucknow for treatments that are at par with the best global standards.
Dr. Nidhi Singh Tandon shared her vision behind the clinic and why she has been so successful in attracting patients from across the country, 'When I started The Skin Art Clinic, my primary goal was to create a place where patients could receive advanced and holistic skincare, combined with the ethical practices of personalized attention and aftercare,' Dr. Nidhi Singh Tandon explained during the press conference.
The clinic stands out for its advanced technology, including Morpheus8 RF Microneedling, ResurFX, IPL Therapy, Venus Freeze, HIFU, and regenerative treatments like PDRN, GFC, and Exosomes. Dr. Nidhi Singh Tandon shared that such technologies have been instrumental in setting the clinic apart. The clinic is the first in Uttar Pradesh, excluding Noida, to introduce Morpheus8, a non-invasive treatment that promotes deep skin remodeling.
When asked,'What inspired you to adopt advanced technologies like Morpheus8 in your clinic', Dr. Nidhi Singh Tandon replied, 'I believe that bringing in advanced technologies is essential for delivering the best results for our patients. Morpheus8, for instance, is one of the most effective treatments for skin tightening and rejuvenation. I adopted it because it's proven to give visible results while minimizing downtime, which is important for today's fast-paced lifestyle.'
Further, when asked, 'How do you ensure a new technology is truly effective and safe for your patients' Dr. Nidhi Singh Tandon explained, 'We conduct thorough in-clinic trials for every new technology we introduce. We rely on global standards and international validation. Every new treatment undergoes rigorous safety checks before being offered to our patients. Our priority is always patient safety and results.'
The clinic's approach to skincare goes beyond just surface-level treatments. Dr. Nidhi Singh Tandon emphasizes a holistic approach that takes into account not just the skin but also a patient's lifestyle, nutrition, and emotional well-being. This has resulted in a loyal patient base who appreciate the personalized care and tailored treatment plans.
Dr. Nidhi Singh Tandon said that the clinic has earned a strong reputation, particularly among celebrities, business leaders, and athletes, who see The Skin Art Clinic as their top choice for skincare. These high-profile clients value privacy and exclusivity.
The clinic's 7-day free follow-up policy is one of the standout features, which is rare in the industry. The Skin Art Clinic also boasts the highest Net Promoter Score (NPS), underscoring its strong referral rates and patient loyalty.
With increasing demand from patients across India, particularly from Uttar Pradesh, Mumbai, Bangalore, and Delhi, The Skin Art Clinic is proving that exceptional skincare doesn't have to come from metro cities. Its cutting-edge technology, personalized care, and ethical practices are setting the clinic apart as a leader in cosmetic dermatology in India.
According to a recent survey conducted by 3EA, The Skin Art Clinic achieved an impressive 72% patient satisfaction rate, surpassing top clinics in Mumbai (67%), Bangalore (64%), and Delhi (58%). These insights were revealed by 3EA during the press conference, underscoring the clinic's growing reputation on a national scale.
Dr. Nidhi Singh Tandon and her team's dedication to innovation and patient care continues to make The Skin Art Clinic the top choice for cosmetic dermatology in Uttar Pradesh and a trusted name across India.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Pharma dept refuses to name 30 docs penalised for Paris, Monaco trip
Pharma dept refuses to name 30 docs penalised for Paris, Monaco trip

New Indian Express

time4 hours ago

  • New Indian Express

Pharma dept refuses to name 30 docs penalised for Paris, Monaco trip

NEW DELHI: Despite a Centre-appointed panel under the Department of Pharmaceuticals (DoP) reprimanding AbbVie Healthcare India Pvt Ltd for violating the uniform code for pharmaceutical marketing practice (UCPMP) by sponsoring trips to Monaco and Paris, in France, for 30 doctors worth Rs 1.91 crore, the department has refused to share the names of the 'offending' doctors against whom action was to be initiated. Revealing the names would involve disclosing personal information of individuals and it was not in public interest, the department said, defending its decision. Notably, the refusal to share the names of the doctors by the DoP under the Ministry of Chemicals and Fertilisers comes five months after activist Dr K V Babu filed an RTI over the matter. Moreover, the DoP is yet to share the names of the doctors with the National Medical Commission (NMC), which was asked by the Apex Committee for Pharma Marketing Practices to take action against the '30 offending healthcare professionals as per Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002' in its order on December 23, 2024. As per the norms, the doctor's licenses can be suspended if found guilty of violating the code of ethics. In its order, the committee also directed the Central Board of Direct Taxes to evaluate the tax liability of AbbVie Healthcare India Pvt Ltd, a subsidiary of US-based pharmaceutical company AbbVie Inc, for unethical marketing practices, along with the 30 doctors, and to take action in accordance with the provisions of the Income Tax Act, 1961.

AP: Serum Institute launches nationwide HPV-Cancer public awareness campaign
AP: Serum Institute launches nationwide HPV-Cancer public awareness campaign

United News of India

time6 hours ago

  • United News of India

AP: Serum Institute launches nationwide HPV-Cancer public awareness campaign

Visakhapatnam, June 13 (UNI) : The 'Conquer HPV & Cancer Conclave 2025' was launched here on Friday as part of a nationwide public health initiative by Pune-based Serum Institute of India Pvt. Ltd, part of Cyrus Poonawalla Group is a global leader in vaccine manufacturing. India continues to face a significant burden of HPV-related diseases, particularly cervical cancer, which remains the second most common cancer among women in the country. According to the ICO/IARC Information Centre on HPV and Cancer (2023), India reports over 1.23 lakh new cervical cancer cases and more than 77,000 related deaths annually. Apart from this up to 90 percent of anal cancers & 63 percent of penile cancers are associated with HPV. At the Visakhapatnam event, a panel of medical specialists engaged in an in-depth discussion about the public health implications of HPV. The panel included Dr. Sunanda Rani Gutta – Director & Chief Consultant Gynaecologist, Nikitha Hospital, Visakhapatnam; Dr. Redla Vidya Rama – Prof. of Obstetrics & Gynecology, Andhra Medical College and King George Hospital; Dr. Sai Sunil Kishore Manem – Chief Neonatologist, Medicover Hospital, Vizag. Associate Professor MIMS Medical College, Vizianagaram and Dr. Buddha Murali Santosh – MBBS, DNB, fellowship in Neonatology. Gold medalist. Neonatologist and Pediatrician at Motherly Women and Children Hospital, Vizag The session was moderated by Dr. Vani Isukapalli – Superintendent, King George Hospital, Visakhapatnam. President-IMA, Visakhapatnam. Together, they highlighted the pressing need for awareness, the importance of reaching both adolescents and parents, and the role of healthcare providers in guiding preventive care. The speakers emphasized that HPV is not limited to cervical cancer alone. It is also associated with cancers of the vulva, vagina, anus, penis, and oropharynx, affecting both men and women. With peak HPV infection occurring between ages 15 to 25, early awareness and timely preventive action are essential. With an affordable HPV vaccine now available, it has become still more easier to protect every individual from HPV associated cancers. 'Through these conclaves held across the country, we aim to increase understanding of Human Papillomavirus (HPV) and its link to cervical and other cancers,' said Parag Deshmukh, Executive Director, Serum Institute of India. 'By bringing together medical experts, healthcare workers, and community members, the forum encourages open dialogue and practical steps toward early detection and prevention,' he said. The Visakhapatnam conclave concluded with an open dialogue involving audience members, reinforcing the broader goal of the campaign: to reduce the burden of preventable cancers through informed decision-making and community engagement. The initiative will continue in cities across the country in the coming months, creating platforms for credible voices in healthcare to educate and empower the public. UNI KNR SSP

Serum, DNDi to develop affordable dengue treatment
Serum, DNDi to develop affordable dengue treatment

Hindustan Times

time7 hours ago

  • Hindustan Times

Serum, DNDi to develop affordable dengue treatment

Serum Institute of India (SII) on Friday signed a memorandum of understanding (MoU) with not-for-profit medical research organisation Drugs for Neglected Diseases initiative (DNDi) to accelerate clinical development of a monoclonal antibody treatment for dengue that will be affordable and accessible in low-and middle-income countries (LMICs). SII and DNDi will develop a work plan to implement research and development, Phase 3 clinical trials, and access activities, along with a joint strategy to raise the necessary funds and resources. SII stated that it has already conducted pre-clinical studies and Phase 1 and 2 clinical trials that show the candidate is safe and effective. It is currently leading the Phase 3 clinical trial in India for licensure. The Pune-based company said a joint project team will be formed to advance clinical trials, with the goal of registering and deploying the dengue monoclonal antibody in India and other countries, provided the studies confirm its safety and efficacy.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store